QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online August 9, 2006
doi: 10.1242/10.1242/jcs.03156

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rusiñol, A. E. Articles by Sinensky, M. S. Search for Related Content PubMed PubMed Citation Articles by Rusiñol, A. E. Articles by Sinensky, M. S.

Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors

Department of Biochemistry and Molecular Biology, Box 70581, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37164-0581, USA

^* Author for correspondence (e-mail: sinensky{at}etsu.edu)

Accepted 4 July 2006

Three mammalian nuclear lamin proteins, lamin B₁, lamin B₂ and the lamin A precursor, prelamin A, undergo canonical farnesylation and processing at CAAX motifs. In the case of prelamin A, there is an additional farnesylation-dependent endoproteolysis, which is defective in two congenital diseases: Hutchinson-Gilford progeria (HGPS) and restrictive dermopathy (RD). These two diseases arise respectively from defects in the prelamin A substrate and the enzyme (ZmpSte24) that processes it. Recent work has shed light on the roles of the lamin proteins and the enzymes involved in their farnesylation-dependent maturation. Other experimental work, including mouse model studies, have examined the possibility that farnesyl transferase inhibitors can represent effective treatment for HGPS. However, there are concerns about their use for this purpose given the potential for alternative prenylation pathways.

Key words: Farnesylation, Lamins, FTIs, HGPS

This article has been cited by other articles:

				E. Meshorer and Y. Gruenbaum Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging J. Cell Biol., April 3, 2008; 181(1): 9 - 13. [Abstract] [Full Text] [PDF]

				T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker, L. Solimando, and R. D. Goldman Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin Genes & Dev., April 1, 2008; 22(7): 832 - 853. [Abstract] [Full Text] [PDF]

				M. W. Kieran, L. Gordon, and M. Kleinman New Approaches to Progeria Pediatrics, October 1, 2007; 120(4): 834 - 841. [Abstract] [Full Text] [PDF]

				S. G. Clarke HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles PNAS, August 28, 2007; 104(35): 13857 - 13858. [Full Text] [PDF]

				E. L. Kilpatrick and J. D. Hildebrandt Sequence Dependence and Differential Expression of G{gamma}5 Subunit Isoforms of the Heterotrimeric G Proteins Variably Processed after Prenylation in Mammalian Cells J. Biol. Chem., May 11, 2007; 282(19): 14038 - 14047. [Abstract] [Full Text] [PDF]

				T. Dechat, T. Shimi, S. A. Adam, A. E. Rusinol, D. A. Andres, H. P. Spielmann, M. S. Sinensky, and R. D. Goldman Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging PNAS, March 20, 2007; 104(12): 4955 - 4960. [Abstract] [Full Text] [PDF]

				S. G. Young, M. Meta, S. H. Yang, and L. G. Fong Prelamin A Farnesylation and Progeroid Syndromes J. Biol. Chem., December 29, 2006; 281(52): 39741 - 39745. [Abstract] [Full Text] [PDF]